- Home
- SRZN vs NUS Comparison
SRZN vs NUS Comparison
Compare SRZN & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRZN | NUS |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 256.3M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SRZN | NUS |
|---|---|---|
| Price | $21.24 | $5.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 169.9K | ★ 746.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $130.63 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $8.21 | $4.89 |
| 52 Week High | $35.00 | $14.62 |
Technical Indicators
Market Signals| Indicator | SRZN | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 50.93 |
| Support Level | $20.26 | $5.19 |
| Resistance Level | $24.50 | $5.44 |
| Average True Range (ATR) | 1.76 | 0.21 |
| MACD | -0.18 | 0.06 |
| Stochastic Oscillator | 22.30 | 78.79 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.